2026 and 2027 Financial Updates. Moderna is expanding its cost efficiency and prioritization programs and expects estimated GAAP operating costs of $5.4 to $5.7 billion in 2026, ...

Lorence Kim, Moderna’s chief financial officer, exercised 241,000 options for $3 million on Monday, filings show. He then immediately sold them for $19.8 million, creating a profit of $16.8 million.

Moderna Inc. released new details about the abrupt departure of Chief Financial Officer Jorge Gomez, saying that it didn’t know of an internal investigation by his former employer Dentsply ...

Moderna's CFO Jorge Gomez will be paid $700,000, despite spending only one day in his new job. Gomez left after his former employer notified the SEC that it was investigating financial reporting.

CAMBRIDGE, MA / ACCESSWIRE / November 2, 2023 / Moderna, Inc. (NASDAQ:MRNA) today reported financial results and provided business updates for the third quarter of 2023. "Through this quarter, we ...

CAMBRIDGE, MA / ACCESS Newswire / April 10, 2025 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 1, 2025 to ...

Finding China’s answer to Moderna comes with huge health warnings for investors. The $87 billion biotechnology giant’s Covid-19 vaccines have inspired copycats in the People’s Republic ...

Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reported financial results and provided business updates for the second ...

Investor Call and Webcast Information . Moderna will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 7, 2020. To access the live conference call, please dial 866-922-5184 ...

Moderna’s Chief Financial Officer, Lorence Kim, M.D., will be leaving the Company in August after six years of service. The Company has retained Russell Reynolds to recruit for a new CFO with ...

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines to create a new generation of transformative medicines for patients, today reported financial results and ...